CD8A and myeloid sarcoma: This suggests that senescent, dysfunctional CD8+ T cells can target glial cells and neurons by direct recognition of the cell and/or myelin sheath via MHC class I or by excessive cytokine production, and therefore they likely play a role in the progression of MS.